Rice will see a big increase in students in the coming years. Rice.edu

Houston's list-topping Ivy League of the South hub is set to see significant growth. Rice University's board of trustees has approved a plan to enlarge its undergraduate student body by 20 percent, the school announced. That means some additional 4,800 students by the fall of 2025.

To accommodate this expansion, Rice will open its 12th residential college and expand the number of students living on campus by approximately one-third — to 3,525.

Rice calculates that its number of graduate students (3,500) is expected to grow, which will bring the total number of undergrad and grad students to about 9,000 by fall 2025. The undergraduate student-faculty ratio would remain roughly the same: about six faculty members for every undergraduate student, the school adds in a press release.

With the newly announced expansion in enrollment, Rice's student body will have grown by around 80 percent over 20 years, per a press release.

This expansion isn't unprecedented: The school notes a roughly 35-percent increase in undergraduate enrollment between fall 2005 and 2013, as well as enlargement in graduate programs.

Not surprisingly, demand for a Rice education is high, as the school reports that the number of students applying to has grown around 75 percent over the last four years. The growth was aided by the Rice Investment, a financial aid program launched in 2018 that significantly expanded support for domestic students from families with incomes up to $200,000.

For example, in 2004, Rice received about 11 applications for every entering student; by 2020, the ratio had grown to roughly 28 applicants for every student opening. Almost 30,000 students applied for fall 2021, marking an increase of 26 percent from the previous year.

Students can expect new construction on the campus, including a new engineering building, a new building for the visual and dramatic arts, an additional residential college, and an expanded student center. The familiar and beloved Rice Memorial Center (the ol' RMC to generations of students) will be replaced; construction will begin in the first quarter of next year.

The school's new three-story, 80,000-square-foot student center will incorporate all of the RMC's current functions, a multicultural center, and gathering and event spaces. The facility will be designed by the international architecture firm Adjaye Associates, which spearheaded the Smithsonian National Museum of African American History and Culture.

Business-minded new students will also be able to take advantage of the university's first undergraduate major in business, which will be offered beginning this fall. Current freshmen and incoming undergraduates are also eligible. Faculty and curriculum will come from the Rice's top-ranked Jones Graduate School of Business.

New students can also take advantage of Rice's newest initiatives, including, per the school:

The Welch Institute at Rice University
Thanks to a massive, $100 million commitment from the Robert E. Welch Foundation (the largest single gift in school history), the institute will accelerate the discovery, design, and manufacture of the next generation of basic materials.

Carbon Hub
The hub, announced in 2019. will direct $100 million of basic science and engineering on an array of technologies, several of which have already been proven in the lab, to create an energy future with zero carbon emissions.

The Rice University National Security Research Accelerator laboratories
A partnership with the Army Futures Command and the Army Research Laboratory represents a new model for collaborative research on critical technologies to enhance national security, a release notes.

"Rice's extraordinary applicant pool has grown dramatically despite the challenges posed by the pandemic," David Leebron, Rice president, noted in a statement. "With the previous expansion we greatly increased our national and international student applications, enrollment and visibility. We also dramatically increased diversity on our campus, and we were able to extend the benefits of a Rice education to many more students. As before, we must undertake this expansion carefully in order to assure that we retain the best aspects of Rice culture, student experience and sense of community."

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

New Houston biotech co. lands $30M for pulmonary fibrosis drug

drug money

Most of us can claim a scar or two on our bodies. But when scarring develops inside the body, it’s known as a fibrotic disorder. A freshly launched Houston company, Oorja Bio Inc., is working on a treatment that can help to repair cells and reduce the damage wrought by the growth of fibrotic tissue in patients.

Late last month, Oorja Bio hit the scene with a pair of big announcements. Not only has the company raised a $30 million Series A thanks to founding investor California-based Westlake BioPartners, but it has also already paved the way for a Phase 2 study to take place this year.

Oorja Bio received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to test its treatment in patients with idiopathic pulmonary fibrosis (IPF), a scarring of the lung tissue. IPF affects more than 150,000 adults in the United States and can result in a range of symptoms from shortness of breath to organ failure and death as it progresses.

Oorja Bio’s lead drug candidate, ORJ-001, was shown in a Phase 1 in-human trial to demonstrate “therapeutically relevant exposure and favorable tolerability” in 64 healthy adult volunteers in whom it was administered daily or weekly, according to a news release. Pre-clinical studies of ORJ-001 showed durable target tissue engagement and biomarker activity in bleomycin-induced lung fibrosis.

Administered subcutaneously, ORJ-001 is intended to improve and even restore function in cells that can reduce the signaling that causes IPF. It stops advancement of IPF and also allows for tissue repair. Currently available treatments for the disease can slow the development of IPF down, but do not address the declining lung function that’s inherent in its progression.

“The clinical and preclinical results from our studies to date give us confidence that ORJ-001 represents a novel treatment approach with the potential to repair and reverse fibrosis and modify disease progression in IPF,” Dr. Janethe Pena, CMO of Oorja Bio, said in the release.

“Our team is energized to deliver on our goal of redefining the future of fibrotic diseases, beginning with ORJ-001,” CEO and founder Sujay Kango added. “As we advance ORJ-001 in the clinic, we are embracing the paradigm shift in our biological understanding of IPF pathology that aligns with the central role of the alveolar epithelium. ORJ-001 was designed with this biology in mind and may provide, for the first time, a therapeutic intervention that repairs and reverses fibrosis and promotes disease modification.”

Most patients live only three to five years following their IPF diagnosis. Soon, ORJ-001 and Oorja Bio could give them a fighting chance.

Axiom Space tops $525M in oversubscribed round, announces Swiss subsidiary

funding boost

Axiom Space tacked on an additional $175 million to a previously announced capital raise, bringing the oversubscribed round to a total of more than $525 million.

Axiom shared in February that it had secured $350 million in a financing round led by Type One Ventures and Qatar Investment Authority. In the latest release from the company, Axiom reports that Japan-based MUFG Bank Ltd. joined the round as a new investor, in addition to continued participation from existing backers.

The funding will go toward developing the company's commercial space station, known as Axiom Station, and the production of its Axiom Extravehicular Mobility Unit (AxEMU) under its NASA spacesuit contract.

“Investor interest in this round outpaced what we set out to raise, which speaks to the moment we’re in,” Jonathan Cirtain, CEO and president of Axiom Space, said in the news release. “Our partners see what is possible in low-Earth orbit, and they see who is positioned to lead it.”

Axiom announced last month that it planned to open a Japanese subsidiary July 1. Earlier this week, it also shared plans to establish Axiom Space Switzerland, a wholly owned subsidiary based in Lucerne that is also expected to begin operations this summer.

The Switzerland subsidiary aims to establish Axiom's presence in Europe and help it partner with the European Space Agency and other space organizations and companies on the continent.

“Europe is a founding leader in the creation of the commercial space economy, and Switzerland is uniquely positioned to convene the government agencies, research institutions, and industrial entities that will shape its next decade,” Cirtain added in a separate release. “Axiom Space Switzerland facilitates the scaling of development and deployment of the infrastructure that will succeed the International Space Station.”

Texas cashes in among 10 best U.S. state economies in 2026 report

State Economics

A new study gauging the success or decline in economic performance in every state has revealed Texas' economy remains stable in 2026 after it dropped out of the top five to No. 8 last year.

Texas boasts the No. 8 best state economy in the U.S. this year, according to WalletHub's annual "Best & Worst State Economies" report. The personal finance website's analysts ranked all 50 states and the District of Columbia across 28 relevant metrics to measure each state's economic activity and health status, and its "innovation potential."

Notably, Texas leads the nation for the most exports per capita in the U.S. in a five-way tie with Louisiana, Kentucky, North Dakota, and Indiana. Across the study's three main categories, Texas ranked highly for its economic activity (No. 7) and economic health (No. 11), and the state's "innovation potential" rank is the 24th best in the nation.

This is how WalletHub ranked Texas' economic performance, where No. 1 is considered the best and No. 25 is considered average:
  • No. 6 – Change in non-farm payrolls
  • No. 8 – Change in GDP
  • No. 8 – Startup activity
  • No. 11 – Annual median household income
  • No. 18 – Government surplus/deficit per capita
  • No. 21 – Percentage of jobs in high-tech industries
  • No. 30 – Unemployment rate
WalletHub previously ranked Texas one of the top three states to start a business in 2026, with Houston earning its own entrepreneurial acclaim in separate rankings of the best big cities for new businesses and for starting a career.

"U.S. economic growth depends heavily on the performance of individual states, and some contribute more than others," the report's author wrote. "For example, California, Texas, New York and Florida have economies so large that if they were countries, they would rank in the top 20 in the world."

The five states with the worst state economies in 2026 are Rhode Island (No. 47), Maine (No. 48), Louisana (No. 49), Kentucky (No. 50), and West Virginia (No. 51).

The top 10 best state economies for 2026 are:

  • No. 1 – Massachusetts
  • No. 2 – Washington
  • No. 3 – Utah
  • No. 4 – California
  • No. 5 – Delaware
  • No. 6 – North Carolina
  • No. 7 – New York
  • No. 8 – Texas
  • No. 9 – Colorado
  • No. 10 – Florida

---

This article originally appeared on CultureMap.com.